Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review

Fangbing Ren1,2,3, Yanhui Ma1,2,3, Kexin Zhang1,2

  • 1Department of Endocrinology and Metabolism, Affiliated Hospital of Weifang Medical University, Weifang, China.

Medicine
|May 3, 2024
PubMed

Insights

Calycosin (CA), a phytoestrogen from traditional Chinese medicine, shows promise as an effective, low-toxicity cancer treatment. It inhibits tumor growth, promotes apoptosis, and enhances chemotherapy efficacy.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products

Background:

  • Cancer presents a significant challenge in oncology, driving the search for novel therapeutics.
  • Calycosin (CA), a phytoestrogen from traditional Chinese medicine, exhibits potential medicinal properties.
  • CA demonstrates low toxicity and high targeting capabilities, with applications in cancer, inflammation, and cardiovascular disease.

Purpose of the Study:

  • To review the antitumor mechanisms of Calycosin (CA).
  • To synthesize current research progress on CA's therapeutic potential in cancer treatment.

Main Methods:

  • Review of existing scientific literature on Calycosin (CA) and its effects on cancer.
  • Analysis of studies detailing CA's mechanisms of action against various cancer types.

Main Results:

  • Calycosin (CA) exhibits inhibitory effects against a diverse range of cancers.
  • CA reduces tumor cell proliferation, induces apoptosis, and suppresses migration and invasion.
  • CA enhances the efficacy of certain chemotherapeutic drugs, indicating a role in combination therapy.

Conclusions:

  • Calycosin (CA) possesses significant potential as a therapeutic agent for cancer treatment due to its efficacy, low toxicity, and multi-targeting characteristics.
  • Further research into CA's antitumor mechanisms and clinical applications is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K